Cell Impact reports first quarter results for 2021

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.

  • Revenues for the first quarter totaled SEK 12.1 million, which is growth of 70% for the quarter.
  • Operating result was SEK -14.4 million during the quarter (-11.5).
  • The Group's result after financial items was SEK -14.7 million (-11.5).
  • Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.25 (-0.25) during the quarter.
  • Equity was SEK 187.2 million (33.6) or SEK 3.18 per share (0.74) on the balance sheet date.
  • Debt/equity ratio was 78% (71%) on the balance sheet date.
  • Cash flows from operating activities amounted to SEK -8.2 million (-12.8) during the quarter.
  • On the balance sheet date, the Group's cash and cash equivalents totaled SEK 129.8 million (2.7).

Significant events in the period

  • January 12, 2021 | Cell Impact appoints Mr Forrest Zhang as China Country Manager
  • March 12, 2021 | Cell Impact receives SEK 42 million order from Plug Power for new production line and flow plates
  • March 15, 2021 | Nowogen Technology places SEK 1.3 million order for serial production of flow plates
  • March 26, 2021 | Cell Impact publishes Annual Report for 2020
  • March 31, 2021 | Cell Impact Japan Inc. office now opened

For more information, please contact:

Stefan Axellie, CFO, +46 70-343 46 55 or stefan.axellie@cellimpact.com.

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA). Contact info: +46 8-528 00 399 or info@fnca.se.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Cell Impact förstärker ledningen med ny COO

Cell Impact AB (Nasdaq First North GM: CI B) meddelar att Daniel Vallin har utsetts till ny operativ chef (COO)med tillträdesdag 16 augusti 2021. Han efterträder Tord Lätt som tar över rollen som projektchef (CPO) med ansvar för bolagets program för automationsutveckling.


Cell Impact strengthens management with new COO

Cell Impact AB (Nasdaq First North GM: CI B) is pleased to announce that Daniel Vallin has been appointed new Chief Operating Officer (COO) and will start his new position on August 16, 2021. He will succeed Tord Lätt, who will take over the role of Chief Project Manager (CPO) with responsibility for Cell Impact's automation development program.


Cell Impact delårsrapport för första kvartalet 2021

Cell Impact AB (Nasdaq First North GM: CI B) lämnar följande finansiella sammanfattning för första kvartalet.


Cell Impact reports first quarter results for 2021

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.


Kommuniké från årsstämma 2021 i Cell Impact

Cell Impact AB (Nasdaq First North GM: CI B) höll under torsdagen den 22 april 2021 årsstämma för verksamhetsåret 2020.


Annual general meeting 2021 of Cell Impact

Cell Impact AB's (Nasdaq First North GM: CI B) annual general meeting for the financial year 2020 was held on 22 April, 2021.


Cell Impact Japan Incs kontor nu öppnat

Cell Impact Japan Inc öppnar nu sitt nya kontor i Minatu-ku-stadsdelen i centrala Tokyo. Företagets uppdrag är att marknadsföra och positionera Cell Impact i den växande japanska vätgasekonomin.


Cell Impact Japan Inc. office now opened

Located in the Minato-ku district in central Tokyo, Cell Impact Japan Inc.'s mission is to market and position Cell Impact in the growing Japanese hydrogen economy.




Kallelse till årsstämma i Cell Impact

Aktieägarna i Cell Impact AB (publ), org.nr 556576-6655, kallas härmed till årsstämma torsdagen den 22 april 2021.


Notice of the annual general meeting of Cell Impact

The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in the annual general meeting to be held on Thursday, 22 April 2021.


Nowogen Technology lägger order på 1,3 MSEK för serieproduktion av flödesplattor

Cell Impact AB (Nasdaq First North GM: CI B) har fått en order värd 1,3 MSEK för serieproduktion av bipolära flödesplattor från Peking-baserade Nowogen Technology i Kina. Ordern är en fortsättning på den prototyporder som Cell Impact fick i september i fjol.


Nowogen Technology places MSEK 1.3 order for serial production of flow plates

Cell Impact AB (Nasdaq First North GM: CI B) has received an order worth MSEK 1.3 for serial production of bipolar flow plates from Beijing-based Nowogen Technology in China. The order is a continuation of the prototype order that Nowogen placed in September last year.


Cell Impact får order på 42 miljoner SEK från Plug Power för ny produktionslinje och flödesplattor

Cell Impact AB (Nasdaq First North GM: CI B) har fått en order till ett värde av 42 miljoner SEK från den världsledande bränslecellsleverantören Plug Power Inc på en Cell Impact Forming™ produktionslinje och flödesplattor för leverans 2021.


Cell Impact receives SEK 42 million order from Plug Power for new production line and flow plates

Cell Impact AB (Nasdaq First North GM: CI B) has received an order worth SEK 42 million from world-leading fuel cell supplier Plug Power Inc for a Cell Impact Forming™ production line and flow plates for delivery during 2021.


Cell Impact delårsrapport för fjärde kvartalet 2020

Cell Impact AB (Nasdaq First North GM: CI B) lämnar följande finansiella sammanfattning för fjärde kvartalet.


Cell Impact reports fourth quarter results for 2020

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the fourth quarter.


Cell Impact utnämner ny chef i Kina

Cell Impact (Nasdaq First North Growth Market: CI B) har utsett Mr. Forrest Zhang till Country Manager i Kina. Mr. Zhang, som kommer att vara baserad i Shanghai, börjar på sin nya post den 3 maj 2021.


Cell Impact appoints China Country Manager

Cell Impact (Nasdaq First North Growth Market: CI B) has appointed Mr. Forrest Zhang as Country Manager in China. Mr. Zhang will be based in Shanghai and will begin his new position on May 3, 2021.


Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
SE-102 45 Stockholm, Sweden

08-692 21 90

Om beQuoted